| ATMPs | Advanced Therapy Medicinal Products |
| AI | Artificial Intelligence |
| BBB | Blood-Brain-Barrier |
| CF-SPPS | Continuous-Flow Solid-Phase Peptide Synthesis |
| CPPs | Cell-penetrating peptides |
| CQAs | critical quality attributes |
| DCs | Dendritic Cells |
| ECs | Endothelial Cells |
| ESCRT | Endosomal Sorting Complexes Required for Transport |
| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| GMP | Good Manufacturing Practices |
| HTS | High-Throughput Screening |
| ICH | International Council for Harmonisation |
| IMPs | Immune-Modulating Peptides |
| MD | Molecular Dynamics |
| ML | Machine Learning |
| MMP | Matrix Metallo Proteinase |
| NIR | Near-Infra Red |
| NK1R | Neurokinin-1 Receptor |
| RGD | Arginine–Glycine–Aspartic acid motif |
| REDV | Arg–Glu–Asp–Val motif |
| QbD | Quality-by-Design |
| PAAs | Polyacrylates |
| RALA | Ras-Related Protein |
| TAT | Trans-Activator of Transcription |